Lipidomics reveals effect of EHHADH in lung squamous cell

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Non-small cell lung cancer (NSCLC) comprises lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD), with distinct lipid metabolism patterns.
• The specific molecular mechanisms of lipid metabolism reprogramming in LUSC are not well understood.

Purpose of the Study:

• To identify and characterize enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase (EHHADH) as a key regulator of medium-chain fatty acid metabolism in LUSC.
• To investigate the role of EHHADH in LUSC cell proliferation and lipid profiles.

Main Methods:

• Data mining to identify highly expressed lipid metabolism genes.
• Investigated EHHADH expression in LUSC and LUAD cell lines.
• Performed EHHADH knockdown and overexpression studies.
• Utilized RNA sequencing and lipidomics analysis.

Main Results:

• EHHADH is highly expressed in LUSC cells compared to LUAD cells.
• EHHADH knockdown reduced LUSC cell proliferation and altered lipid profiles, decreasing medium-chain fatty acids and increasing long-chain fatty acids and storage lipids.
• RNA sequencing revealed significant changes in lipid metabolism-related gene expression post-EHHADH silencing.

Conclusions:

• EHHADH is a crucial regulator of lipid metabolism in LUSC, influencing cell proliferation and lipid profiles.
• EHHADH plays a significant role in the occurrence, progression, and treatment of lung cancer.
• EHHADH presents potential as a diagnostic biomarker and therapeutic target for personalized lung cancer treatment.